Novel software measures the significance of specific genomic biomarkers to help predict diseases

IntelliGenes, a first of its kind software created at Rutgers Health, combines artificial intelligence (AI) and machine-learning approaches to measure the significance of specific genomic biomarkers to help predict diseases in individuals, according to its developers.

AstraZeneca CEO reaffirms commitment to China following executive’s detention

NEW YORK — AstraZeneca is not backing away from China despite an investigation into its president of China operations. As the company reported its third-quarter

November 13, 2024

AdvaMed elevates digital health center to division, names board

Dive Brief: AdvaMed has launched a new division to promote the role of data and digital medical technologies in healthcare. The AdvaMed Digital Health Tech

October 10, 2023

Reunion Neuroscience Inc. to Participate in October Investor Conferences | Psychedelic Invest

Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, today announced that

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.